Nav1.8 channels in ganglionated plexi modulate atrial fibrillation inducibility

Cardiovascular Research

Volumn 102, Issue 3, 2014, Pages 480-486

  Qi, Baozhen ^a   Wei, Yong ^a   Chen, Songwen ^a   Zhou, Genqing ^a   Li, Hongli ^a   Xu, Juan ^a   Ding, Yu ^a   Lu, Xiaofeng ^a   Zhao, Liqun ^a   Zhang, Feng ^a   Chen, Gang ^a   Zhao, Jing ^b   Liu, Shaowen ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Atrial fibrillation; Ganglionated plexus; SCN10A; Sodium channel; Vagus nerve

Indexed keywords

5 ( 4 CHLOROPHENYL) N ( 3,5 DIMETHOXYPHENYL)FURAN 2 CARBOXAMIDE; A 803467; DIMETHYL SULFOXIDE; MACROGOL; SODIUM CHANNEL BLOCKING AGENT; SODIUM CHANNEL NAV1.8; UNCLASSIFIED DRUG; ANILINE DERIVATIVE; FURAN DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CANINE MODEL; CARDIAC GANGLIONATED PLEXI; CONTROLLED STUDY; ELECTRIC POTENTIAL; GANGLION; HEART; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART CONDUCTION; HEART MUSCLE REFRACTORY PERIOD; MALE; MONGREL DOG; NONHUMAN; PR INTERVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SINUS RHYTHM; VAGUS NERVE STIMULATION; ANIMAL; ATRIAL FIBRILLATION; AUTONOMIC GANGLION; DOG; DRUG EFFECTS; ELECTROCARDIOGRAPHY; ELECTROSTIMULATION; INNERVATION; PHYSIOLOGY; REFRACTORY PERIOD; VAGUS NERVE;

ANILINE COMPOUNDS; ANIMALS; ATRIAL FIBRILLATION; DOGS; ELECTRIC STIMULATION; ELECTROCARDIOGRAPHY; FURANS; GANGLIA, AUTONOMIC; HEART; MALE; NAV1.8 VOLTAGE-GATED SODIUM CHANNEL; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL; VAGUS NERVE;

EID: 84901436785     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvu005     Document Type: Article

References (38)

1. Benjamin EJ, Chen PS, Bild DE, Mascette AM, Albert CM, Alonso A et al. Prevention of atrial fibrillation: Report from a national heart, lung, and blood institute workshop. Circulation 2009;119: 606-618.
2. Chen YJ, Chen SA, Tai CT, Wen ZC, Feng AN, Ding YA et al. Role of atrial electrophysiology and autonomic nervous system in patients with supraventricular tachycardia and paroxysmal atrial fibrillation. J Am Coll Cardiol 1998;32: 732-738.
3. Hou Y, Scherlag BJ, Lin J, Zhang Y, Lu Z, Truong K et al. Ganglionated plexi modulate extrinsic cardiac autonomic nerve input: Effects on sinus rate, atrioventricular conduction, refractoriness, and inducibility of atrial fibrillation. J Am Coll Cardiol 2007;50: 61-68.
4. Chiou CW, Eble JN, ZipesDP. Efferent vagal innervation of the canine atria and sinus and atrioventricular nodes. The third fat pad. Circulation 1997;95: 2573-2584.
5. Schauerte P, Scherlag BJ, Pitha J, Scherlag MA, Reynolds D, Lazzara R et al. Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation. Circulation 2000;102: 2774-2780.
6. Scherlag BJ, YamanashiW, Patel U, Lazzara R, JackmanWM.Autonomically induced conversion of pulmonary vein focal firing into atrial fibrillation. J Am Coll Cardiol 2005;45: 1878-1886.
7. Po SS, Scherlag BJ, Yamanashi WS, Edwards J, Zhou J, WuR et al. Experimental model for paroxysmal atrial fibrillation arising at the pulmonary vein-atrial junctions. Heart Rhythm 2006;3: 201-208.
8. Pappone C, Santinelli V, Manguso F, Vicedomini G, Gugliotta F, Augello G et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 2004;109: 327-334.
9. Scherlag BJ, Nakagawa H, JackmanWM, Yamanashi WS, Patterson E, Po S et al. Electrical stimulation to identify neural elements on the heart: Their role in atrial fibrillation. J Interv Card Electrophysiol 2005;13: 37-42.
10. Akopian AN, Sivilotti L, Wood JN. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature 1996;379: 257-262.
11. Akopian AN, Souslova V, England S, Okuse K, Ogata N, Ure J et al. The tetrodotoxinresistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci 1999;2: 541-548.
12. Verkerk AO, Remme CA, Schumacher CA, Scicluna BP, Wolswinkel R, de Jonge B et al. Functional NaV1.8 channels in intracardiac neurons: The link between SCN10A and cardiac electrophysiology. Circ Res 2012;111: 333-343.
13. Chambers JC, Zhao J, Terracciano CM, Bezzina CR, ZhangW, Kaba R et al. Genetic variation in SCN10A influences cardiac conduction. Nat Genet 2010;42: 149-152.
14. Holm H, Gudbjartsson DF, Arnar DO, Thorleifsson G, Thorgeirsson G, Stefansdottir H et al. Several common variants modulate heart rate, PR interval and QRS duration. Nat Genet 2010;42: 117-122.
15. Sotoodehnia N, Isaacs A, de Bakker PI, Dö rr M, Newton-Cheh C, Nolte IM et al. Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet 2010;42: 1068-1076.
16. Ritchie MD, Denny JC, Zuvich RL, Crawford DC, Schildcrout JS, Bastarache L et al. Genome-and phenome-wide analyses of cardiac conduction identifies markers of arrhythmia risk. Circulation 2013;127: 1377-1385.
17. Pfeufer A, van Noord C, Marciante KD, Arking DE, Larson MG, Smith AVet al. Genomewide association study of PR interval. Nat Genet 2010;42: 153-159.
18. Jarvis MF, Honore P, Shieh CC, Chapman M, Joshi S, Zhang XF et al. A-803467, a potent and selective NaV1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc Natl Acad Sci USA 2007;104: 8520-8525.
19. McGaraughty S, Chu KL, Scanio MJ, Kort ME, Faltynek CR, Jarvis MF. A selective NaV1.8 sodium channel blocker, A-803467 [5-(4-chlorophenyl-N-(3, 5-dimethoxyphenyl)-furan-2-carboxamide], attenuates spinal neuronal activity in neuropathic rats. J Pharmacol Exp Ther 2008;324: 1204-1211.
20. Kort ME, Drizin I, Gregg RJ, Scanio MJ, Shi L, Gross MF et al. Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the NaV1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain. J Med Chem 2008;51: 407-416.
21. Joshi SK, Honore P, Hernandez G, Schmidt R, Gomtsyan A, ScanioMet al. Additive antinociceptive effects of the selective NaV1.8 blocker A-803467 and selective TRPV1 antagonists in rat inflammatory and neuropathic pain models. J Pain 2009;10: 306-315.
22. Yang T, Atack TC, Stroud DM, ZhangW, Hall L, Roden DM. Blocking Scn10a channels in heart reduces late sodium current and is antiarrhythmic. Circ Res 2012;111: 322-332.
23. OhS, Choi EK, Zhang Y, Mazgalev TN. Botulinum toxin injection in epicardial autonomic ganglia temporarily suppresses vagally mediated atrial fibrillation. Circ Arrhythm Electrophysiol 2011;4: 560-565.
24. Wang Z, Page P, Nattel S. Mechanismof flecainide's antiarrhythmic action in experimental atrial fibrillation. Circ Res 1992;71: 271-287.
25. Liu L, Nattel S. Differing sympathetic and vagal effects on atrial fibrillation in dogs: Role of refractoriness reterogeneity. Am J Physiol 1997;273: H805-H816.
26. Prechtl JC, Powley TL. The fiber composition of the abdominal vagus of the rat. Anat Embryol 1990;181: 101-115.
27. Pauza DH, Skripka V, Pauziene N, Stropus R. Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart. Anat Rec 2000;259: 353-382.
28. Quan KJ, Lee JH, Van HareGF, Biblo LA, Mackall JA, Carlson MD. Identification and characterization of atrioventricular parasympathetic innervation in humans. J Cardiovasc Electrophysiol 2002;13: 735-739.
29. Po SS, Nakagawa H, JackmanWM.Localization of left atrial ganglionated plexi in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2009;20: 1186-1189.
30. Hoover DB, Isaacs ER, Jacques F, Hoard JL, Pagé P, Armour JA. Localization of multiple neurotransmitters in surgically derived specimens of human atrial ganglia. Neuroscience 2009;164: 1170-1179.
31. Cheng S, Keyes MJ, Larson MG, McCabe EL, Newton-Cheh C, Levy D et al. Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA 2009;301: 2571-2577.
32. Soliman EZ, Prineas RJ, Case LD, Zhang ZM, Goff DCJr. Ethnic distribution of ECG predictors of atrial fibrillation and its impact on understanding the ethnic distribution of ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2009;40: 1204-1211.
33. Schnabel RB, Sullivan LM, Levy D, Pencina MJ, Massaro JM, D'Agostino RBSR, et al. Development of a Risk Score for Atrial Fibrillation (The Framingham Heart Study): A community-based cohort study. The Lancet 2009;373: 739-745.
34. Magnani JW, Wang N, Nelson KP, Connelly S, Deo R, Rodondi N et al. Electrocardiographic PR interval and adverse outcomes in older adults: The Health, Aging, and Body Composition study. Circ Arrhythm Electrophysiol 2013;6: 84-90.
35. Facer P, Punjabi PP, Abrari A, Kaba RA, Severs NJ, Chambers J et al. Localisation of SCN10A gene product Na(v)1.8 and novel pain-related ion channels in human heart. Int Heart J 2011;52: 146-152.
36. Kukanova B, Mravec B. Complex intracardiac nervous system. Bratisl Lek Listy 2006;107: 45-51.
37. Blasiusa AL, Dubinb AE, Petrusc MJ, Lim BK, Narezkina A, Criado JR et al. Hypermorphic mutation of the voltage-gated sodium channel encoding gene Scn10a causes a dramatic stimulus-dependent neurobehavioral phenotype. Proc Natl Acad Sci USA 2011;108: 19413-19418.
38. Herring N, Paterson DJ. Nitric oxide-cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea-pig in vitro. J Physiol 2001;535: 507-518.